Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (not Standard BioTools Inc.) on February 10, 2021. The filing serves to announce the issuance of a press release detailing financial results for the quarter and full year ended December 31, 2020. The company is incorporated in Delaware and trades on the Nasdaq Global Select Market under the symbol FLDM.
Key Financial Metrics
The provided text is a cover sheet for the 8-K filing and does not contain specific numerical data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, no specific financial values are available in this text.
Material Changes
The filing text does not provide specific comparative data or describe material changes versus the prior period. It only confirms that results for the period ended December 31, 2020, have been reported via a separate press release.
Guidance, Outlook, and Risks
The text contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It explicitly states that the information furnished in this report and the attached press release is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant name: The filing is for Fluidigm Corporation, not Standard BioTools Inc.
- Review Exhibit 99.1 (the Press Release dated February 10, 2021) for actual financial figures, as they are absent from this cover document.
- Confirm the reporting period covers the quarter and full year ended December 31, 2020.
- Note that the information is "furnished" rather than "filed," limiting its legal incorporation into future SEC documents.